Citation: T. Sumi et al., Bleomycin, actinomycin-D, and cisplatin treatment of ovarian germ-cell malignancies contributes to reducing adverse drug reactions, ONCOL REP, 7(6), 2000, pp. 1235-1238
Authors:
Hirai, K
Ishiko, O
Sumi, T
Kanaoka, Y
Ogita, S
Citation: K. Hirai et al., Kinetics of plasma platinum in a hemodialysis patient receiving repeated doses of cisplatin, ONCOL REP, 7(6), 2000, pp. 1243-1245
Authors:
Umesaki, N
Tanaka, T
Miyama, M
Kawabe, J
Okamura, T
Koyama, K
Ochi, H
Ogita, S
Citation: N. Umesaki et al., The role of F-18-fluoro-2-deoxy-D-glucose positron emission tomography (F-18-FDG-PET) in the diagnosis of recurrence and lymph node metastasis of cervical cancer, ONCOL REP, 7(6), 2000, pp. 1261-1264
Authors:
Umesaki, N
Tanaka, T
Miyama, M
Morimura, M
Ogita, S
Citation: N. Umesaki et al., Postoperative adjuvant chemotherapy with cisplatin, etoposide, and pirarubicin for endometrial carcinoma patients with lymph node metastasis: A pilotstudy, ONCOL REP, 7(5), 2000, pp. 1083-1086
Authors:
Ishiko, O
Sumi, T
Yasui, T
Matsumoto, Y
Ogita, S
Kaminou, T
Nakamura, K
Yamada, R
Citation: O. Ishiko et al., Tumor marker and MR imaging criteria for evaluating the efficacy of cyclicballoon-occluded arterial infusion for advanced cancer of the uterine cervix, ONCOL REP, 7(4), 2000, pp. 827-830
Authors:
Matsumoto, Y
Ishiko, O
Deguchi, M
Ueda, K
Ogita, S
Haba, T
Wakasa, K
Citation: Y. Matsumoto et al., Clinical significance of mucin staining in keratinizing-type squamous cellcarcinoma of the uterine cervix, ONCOL REP, 7(4), 2000, pp. 867-869
Authors:
Matsumoto, Y
Deguchi, M
Ishiko, O
Ogita, S
Citation: Y. Matsumoto et al., Retrospective study of the prognostic factors of remission induction for single-agent chemotherapy with cisplatin in advanced epithelial ovarian cancer, ONCOL REP, 7(2), 2000, pp. 311-313
Authors:
Umesaki, N
Miyama, M
Tokuyama, O
Kawamura, N
Ogita, S
Kawabe, J
Okamura, T
Koyama, K
Ochi, H
Ochi, H
Citation: N. Umesaki et al., Early diagnosis and evaluation of therapy in postoperative recurrent cervical cancers by positron emission tomography, ONCOL REP, 7(1), 2000, pp. 53-56
Authors:
Ishiko, O
Sumi, T
Yasui, T
Matsumoto, Y
Kawamura, N
Ogita, S
Kamino, T
Nakamura, K
Yamada, R
Citation: O. Ishiko et al., Balloon-occluded arterial infusion chemotherapy, simple total hysterectomy, and radiotherapy as a useful combination-therapy for advanced cancer of the uterine cervix, ONCOL REP, 7(1), 2000, pp. 141-144
Authors:
Tanaka, T
Miyama, M
Masuda, M
Mizuno, K
Sakamoto, T
Umesaki, N
Ogita, S
Citation: T. Tanaka et al., Production and physiological function of granulocyte colony-stimulating factor in non-pregnant human endometrial stromal cells, GYNECOL END, 14(6), 2000, pp. 399-404
Citation: T. Tanaka et al., Altered sensitivity to anti-endometriosis medicines in an adenomyosis patient with thyroid dysfunction, GYNECOL END, 14(5), 2000, pp. 388-391
Authors:
Tanaka, T
Umesaki, N
Masuda, M
Mizuno, K
Ogita, S
Citation: T. Tanaka et al., Enhancement of human endometrial stromal decidualization by bestatin, an aminopeptidase-N inhibitor, GYNECOL END, 14(3), 2000, pp. 182-186
Authors:
Katsumata, N
Tsunematsu, R
Tanaka, K
Terashima, Y
Ogita, S
Hoshiai, H
Kohno, I
Hirabayashi, K
Yakushiji, M
Noda, K
Taguchi, T
Citation: N. Katsumata et al., A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: A Japanese Cooperative Study, ANN ONCOL, 11(12), 2000, pp. 1531-1536
Citation: T. Tanaka et al., Camptothecin and mitomycin combination chemotherapy on ovarian clear cell carcinoma with multiple systemic metastases, EUR J GYN O, 21(4), 2000, pp. 377-379
Citation: N. Umesaki et al., Effect of adjuvant chemotherapy using pirarubicin, cisplatin, and etoposide (PEP) for stage IVB endometrial carcinoma: A case report, EUR J GYN O, 21(3), 2000, pp. 303-304
Authors:
Nishimura, S
Ishiko, O
Honda, K
Hyun, Y
Ogita, S
Citation: S. Nishimura et al., New cervicoscopy with toluidine blue staining for superficial cervical invasion by endometrial carcinoma, GYNECOL OBS, 50(2), 2000, pp. 133-135
Authors:
Sumi, T
Ishiko, O
Hirai, K
Yoshida, H
Ogita, S
Citation: T. Sumi et al., Is measuring the posterior urethrovesical angle of clinical value for controlling pelvic organ prolapse? Retrospective analysis of 107 postoperative cases, GYNECOL OBS, 49(3), 2000, pp. 183-186